Acute kidney injury in paediatric patients with sickle cell disease is associated with increased morbidity and resource utilization
- PMID: 32030722
- DOI: 10.1111/bjh.16384
Acute kidney injury in paediatric patients with sickle cell disease is associated with increased morbidity and resource utilization
Abstract
Renal disease is a common complication experienced by patients with sickle cell disease (SCD), though the epidemiology of acute kidney injury (AKI) in paediatric patients and its impact on long-term renal outcomes is unclear. We utilized the Pediatric Health Information System (PHIS) to identify inpatient encounters of paediatric patients with SCD admitted for vaso-occlusive pain crisis (VOC). Overall, 1·4% of patients experienced at least one episode of AKI and 2·5% of admissions were complicated by AKI. Patients with at least one episode of AKI were more likely to be adolescents or young adults at the time of their initial admission, had increased rates of admission to the ICU, longer lengths of stay, increased costs of hospitalization, increased risk of readmission and increased rates of SCD-related comorbidities. Generalized estimating equation modelling demonstrated that increasing age, history of hypertension, history of haematuria and history of chronic kidney disease were associated with increased odds of developing AKI, though hydroxycarbamide use (OR 0·64, 95% CI 0·44-0·94) was protective. Episodes of AKI during hospitalization in children with SCD are associated with increased morbidity and utilization of hospital resources. Increasing the use of hydroxycarbamide may decrease the likelihood of this complication.
Keywords: Epidemiology; acute kidney injury; hydroxycarbamide; paediatric; sickle cell disease.
© 2020 British Society for Haematology and John Wiley & Sons Ltd.
References
-
- Alkandari, O., Eddington, K.A., Hyder, A., Gauvin, F., Ducruet, T., Gottesman, R., Phan, V. & Zappitelli, M. (2011) Acute kidney injury is an independent risk factor for paediatric intensive care unit mortality, longer length of stay and prolonged mechanical ventilation in critically ill children: a two-center retrospective cohort study. Critical Care, 15, R146.
-
- Alvarez, O., Miller, S.T., Wang, W.C., Luo, Z., McCarville, M.B., Schwartz, G.J., Thompson, B., Howard, T., Iyer, R.V., Rana, S.R., Rogers, Z.R., Sarnaik, S.A., Thornburg, C.D. & Ware, R.E. (2012) Effect of hydroxyurea treatment on renal function parameters: results from the multi-center placebo-controlled BABY HUG clinical trial for infants with sickle cell anemia. Pediatric Blood and Cancer, 59, 668-674.
-
- Audard, V., Homs, S., Habibi, A., Galacteros, F., Bartolucci, P., Godeau, B., Renaud, B., Levy, Y., Grimbert, P., Lang, P., Brun-Buisson, C., Brochard, L., Schortgen, F., Maitre, B. & Dessap, A.M. (2010) Acute kidney injury in sickle patients with painful crisis or acute chest syndrome and its relation to pulmonary hypertension. Nephrology Dialysis Transplantation, 25, 2524-2529.
-
- Baddam, S., Aban, I., Hilliard, L., Howard, T., Askenazi, D. & Lebensburger, J.D. (2017) Acute kidney injury during a paediatric sickle cell vaso-occlusive pain crisis. Pediatric Nephrology, 32, 1451-1456.
-
- Bartolucci, P., Habibi, A., Stehle, T., Di Liberto, G., Rakotoson, M.G., Gellen-Dautremer, J., Loric, S., Moutereau, S., Sahali, D., Wagner-Ballon, O., Remy, P., Lang, P., Grimbert, P., Audureau, E., Godeau, B., Galacteros, F. & Audard, V. (2016) Six months of hydroxyurea reduces albuminuria in patients with sickle cell disease. Journal of the American Society of Nephrology, 27, 1847-1853.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
